(7) Locatelli V, Bianchi VE
doi: 10.3389/fendo.2025.1708007 Received 18 September 2025 Revised 30 November 2025 Accepted 01 December 2025 Published 15 December 2025 Volume 16 - 2025 Edited by Dipak Kumar Sahoo, Iowa State University, United States Reviewed by Fernando Hinostroza, Universidad Catlica del Maule, Chile Anil Patani, Sankalchand Patel University, India Updates Copyright 2025 Park
Bone Healing BPC-157 promotes osteoblast activity and angiogenesis in fractured bone, which may accelerate bone remodeling and union
Jego waciwoci przeciwzapalne i zdolno do modulowania reakcji immunologicznych mog mie zastosowanie w szerokim spektrum chorb autoimmunologicznych
Zepbound (tirzepatide) On February 23, 2026, Novo Nordisk shared results from a study that directly compared CagriSema to Zepbound